We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

MINDRAY In-Vitro Diagnostics

As a global leader in in-vitro diagnostics, Mindray provides a wide range of efficient, reliable IVD solutions for la... read more Featured Products: More products

Download Mobile App





Mindray Presents Range of IVD Total Solutions for Laboratories of All Sizes

By LabMedica International staff writers
Posted on 04 Feb 2025

Mindray (Shenzhen, China) is exhibiting its comprehensive range of IVD total solutions designed for laboratories of all sizes. More...

Visitors to the Mindray booth can discover its exciting new innovations, including the CAL 9000 All-in-One Hematology Solution, the M980 Chemistry and Immunoassay Integrated Solution, and the FA-N60 Automated Blood Culture System, all aimed at enhancing laboratory efficiency.

The CAL 9000 is Mindray’s latest generation of advanced hematology cellular analysis line. It delivers CBC, ESR, and HbA1c results from a single EDTA tube using the "All-in-One" solution. Additionally, it features fully automated sample processing, and accurate disease-specific alarms which enable intelligent re-examination and digital morphology analysis. This high-performance line enhances diagnostic accuracy, reduces manual workload, and accelerates clinical decision-making for laboratories. The M980 is a powerful and efficient chemistry and immunoassay integrated solution with a compact footprint of just 2.6 m². Featuring innovative technologies such as the PDR platform, auto de-capping, ultrasonic probe washing, and FS sampling, it efficiently delivers reliable reports for patient care.

The FA-N60 is a next-generation scalable blood culture system that features real-time blood volume monitoring, an intelligent satellite information transmission system, and newly designed culture bottles. It enables rapid diagnosis of bloodstream infections with an optimized workflow. The fully automatic AF-300 ID/AST system offers a range of combinations using Mindray combo ID/AST cards. It can identify over 500 bacterial species with high sensitivity and employs direct minimum inhibitory concentrations (MICs) to detect emerging resistant pathogens, following CLSI and EUCAST guidelines. This ensures timely and accurate results for clinical microbiology testing. The BriCyte MX Flow Cytometer is optimized for configuration and performance, featuring an optical system with up to 3 lasers and 14 colors. It boasts significant improvements in key performance metrics, including multi-mode fluorescence compensation, expanded automatic algorithms, and innovative automated review, making flow cytometry analyses more standardized and efficient.

 


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Varicella Zoster Test
ZEUS ELISA Varicella Zoster IgG Test System
New
Silver Member
Luteinizing Hormone Test
Luteinizing Hormone (LH) Rapid Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.